Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Caribou Biosciences, Inc. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
lymphoma
lymphoma, non-hodgkin, relapsed non hodgkin lymphoma, refractory b-cell non-hodgkin lymphoma, non hodgkin lymphoma, lymphoma, b cell lymphoma, b cell non-hodgkin's lymphoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 837738
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.